Serologic response to human papillomavirus 16 among Australian women with high-grade cervical intraepithelial neoplasia

International Journal of Gynecological Cancer

Volumn 16, Issue 3, 2006, Pages 1032-1035

  Tabrizi, S N ^a,c   Frazer, I H ^b   Garland, S M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c ROYAL WOMEN'S HOSPITAL   (Australia)

Author keywords

Cervical cancer; CIN; HPV; Serology; VLP

Indexed keywords

VIRUS ANTIBODY; VIRUS DNA;

ANTIBODY RESPONSE; ARTICLE; DISEASE ASSOCIATION; DISEASE MARKER; DNA SCREENING; FEMALE; HIGH GRADE UTERINE CERVIX INTRAEPITHELIAL NEOPLASIA; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; SEROLOGY; SEROPREVALENCE; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; VIRUS GENOME; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS PARTICLE; VIRUS VIRULENCE;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL; AUSTRALIA; CERVICAL INTRAEPITHELIAL NEOPLASIA; CROSS-SECTIONAL STUDIES; DNA PROBES, HPV; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS;

EID: 33745089190     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00587.x     Document Type: Article

References (21)

1. Schiffman MH Bauer HM Hoover RN et al. Epidemiological evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993 85 : 958 64.
2. Fairley CK Chen S Tabrizi SN Quinn M McNeil JJ Garland SM. A novel method for the assessment of human papillomavirus infection. J Infect Dis 1992 165 : 1103 6.
3. Schiffman MH. Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia. J Nat Cancer Int 1992 84 : 394 8.
4. Walboomers JM Jacobs MV Manos MM et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999 189 : 12 9.
5. Schiffman M Herrero R DeSalle R et al. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 2005 337 : 76 84.
6. Carter JJ Koutsky LA Hughes JP et al. Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis 2000 181 : 1911 9.
7. Dunne EF Karem KL Sternberg MR et al. Seroprevalence of human papillomavirus type 16 in children. J Infect Dis 2005 191 : 1817 9.
8. Stone KM Karem KL Sternberg MR et al. Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis 2002 186 : 1396 402.
9. Nonnenmacher B Pintos J Bozzetti MC et al. Epidemiologic correlates of antibody response to human papillomavirus among women at low risk of cervical cancer. Int J STD AIDS 2003 14 : 258 65.
10. Tabrizi SN Fairley CK Chen S et al. Epidemiological characteristics of women with high grade CIN who do and do not have human papillomavirus. Br J Obstet Gynaecol 1999 106 : 252 7.
11. Zhou J Sun XY Davies H Crawford L Park D Frazer IH. Definition of linear antigenic regions of the HPV16 L1 capsid protein using synthetic virion-like particles. Virology 1992 189 : 592 9.
12. Carter JJ Koutsky LA Wipf GC et al. The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women. J Infect Dis 1996 174 : 927 36.
13. Lehtinen M Pawlita M Zumbach K et al. Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later. Am J Obstet Gynecol 2003 188 : 49 55.
14. Strickler HD Schiffman MH Shah KV et al. A survey of human papillomavirus 16 antibodies in patients with epithelial cancers. Eur J Cancer Prev 1998 7 : 305 13.
15. Konya J Dillner J. Immunity to oncogenic human papillomaviruses. Adv Cancer Res 2001 82 : 205 28.
16. Giroglou T Sapp M Lane C et al. Immunological analyses of human papillomavirus capsids. Vaccine 2001 19 : 1783 93.
17. Pastrana D Vass WC Lowy DR Schiller JT. NHPV 16 VLP vaccine induces human antibodies that neutralize divergent variants of HPV 16. Virology 2001 279 : 361 9.
18. Kjellberg L Wang Z Wiklund F et al. Sexual behaviour and papillomavirus exposure in cervical intraepithelial neoplasia: a population-based case-control study. J Gen Virol 1999 80 : 391 8.
19. Marais DJ Rose RC Lane C et al. Seroresponses to human papillomavirus types 16, 18, 31, 33, and 45 virus-like particles in South African women with cervical cancer and cervical intraepithelial neoplasia. J Med Virol 2000 60 : 403 10.
20. Matsumoto K Yoshikawa H Yasugi T et al. IgG antibodies to human papillomavirus 16, 52, 58, and 6 L1 capsids: case-control study of cervical intraepithelial neoplasia in Japan. J Med Virol 2003 69 : 441 6.
21. Dillner J. The serological response to papillomaviruses. Semin Cancer Biol 1999 9 : 423 30.